Merck & Co. Inc. said Friday that a Phase 3 trial evaluating Keytruda as a first-line treatment for gastric cancer failed to show improvement in patients' overall or progression-free survival when compared with chemotherapy. Shares of the drugmaker were down 0.05% in premarket trade. An earlier Phase 3 study looking at Keytruda as a second-line treatment for gastric cancer also failed to show a survival benefit, though the Food and Drug Administration did approve the drug in 2017 as a third-line treatment for patients with advanced gastric cancer. Keytruda is currently used for many other cancer indications, including treating certain subsets of patients with melanoma, lung cancer, Hodgkin lymphoma and cervical cancer, among many others. Shares of the pharmaceutical giant have fallen 0.1% in the year to date, while the S&P 500 has gained 16.7%.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Merck's Keytruda wins FDA approval as combination therapy for kidney cancerThe U.S. Food and Drug Administration has approved Merck & Co Inc's cancer ...
Read more »
The CEO of pharmaceutical giant Merck is a Harvard-trained lawyer, and he shares what attorneys need to do to be 'treated as the wise people in the room' againHere's why it's a mistake for lawyers to specialize too much, and what they should do instead, according to the attorney who runs the pharma company Merck.
Read more »
Merck's Keytruda wins FDA approval as combination therapy for kidney cancerThe U.S. Food and Drug Administration has approved Merck & Co Inc's cancer ...
Read more »
Possible 2020 contender Michael Bennet gets clean bill of health after cancer treatmentColorado Sen. Michael Bennet, who is contemplating jumping in the crowded 2020 Democratic presidential race, has been given a clean bill of health after undergoing surgery to remove cancer, his office said in a statement.
Read more »
Experimental treatment for peanut allergy increases anaphylaxis risk, study findsAn experimental treatment for peanut allergy may actually multiply someone's risk for serious allergic reactions -- much like the ones it aims to prevent, according to a new analysis.
Read more »
Possible 2020 contender Michael Bennet gets clean bill of health after cancer treatmentColorado Sen. Michael Bennet, who is contemplating jumping in the crowded 2020 Democratic presidential race, has been given a clean bill of health after undergoing surgery to remove cancer, his office said in a statement.
Read more »
Medicare proposes higher payments for innovative cancer treatmentIf approved, the increased reimbursements for CAR T-cell therapy and “breakthrough” devices would go into effect on Oct. 1.
Read more »
Eli Lilly to Pull Cancer Drug From Market After Failed StudyEli Lilly plans to withdraw its cancer drug Lartruvo from the market after a study showed that it failed to prolong overall survival in a clinical trial.
Read more »
This Line Of Bags Is Manufactured With Algae - And The First Run Is Almost Sold OutTentree's newest line of bags uses foam made from naturally occurring algae. Algae-filled water is pulled out of lakes and filtered before the clean water is returned to the environment; a process that Tentree's CEO says leaves the water cleaner than when they found it.
Read more »
April job gains could be way better than expected if one forecast is rightBofAML economists already are forecasting a big upside surprise. They see job expansion of 250,000 jobs, ahead of the current Dow Jones estimate of 196,000
Read more »
Jerrie Cobb, decorated pilot once in line to become first female astronaut, dies at 88She performed better than many of her male peers, but in the early 1960s NASA decided against sending women into space.
Read more »